Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells

Oncogene

Volumn 23, Issue 25, 2004, Pages 4488-4494

  Li, H M ^a   Zhuang, Zh ^a   Wang, Q ^a   Pang, J C S ^c   Wang, X H ^a   Wong, H L ^a   Feng, H C ^a   Jin, D Y ^b   Ling, M T ^a   Wong, Y C ^a   Eliopoulos, A G ^d   Young, L S ^d   Huang, D P ^c   Tsao, S W ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c Institute of Molecular Oncology   (Hong Kong)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Epstein Barr virus; Id1; LMP1; Nasopharyngeal carcinoma; Nuclear factor B

Indexed keywords

INHIBITOR OF DIFFERENTIATION 2; PROTEIN P16; VIRUS PROTEIN; EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; ID1 PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF DIFFERENTIATION 1; MATRIX PROTEIN; PROTEIN P16INK4A; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL IMMORTALIZATION; CELL PROLIFERATION; EPITHELIUM CELL; EPSTEIN BARR VIRUS; HELIX (SNAIL); HUMAN; HUMAN CELL; KIDNEY CELL; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VIRUS INFECTION; BIOSYNTHESIS; CARCINOMA; CELL CLONE; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HONG KONG; METABOLISM; NASOPHARYNX; NASOPHARYNX TUMOR; PATHOLOGY; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; TUMOR SUPPRESSOR GENE; VIROLOGY;

DNA VIRUSES; GASTROPODA; HELIX (SNAIL); HUMAN HERPESVIRUS 4;

CARCINOMA; CLONE CELLS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; EPITHELIAL CELLS; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION REGULATION, VIRAL; GENES, P16; HERPESVIRUS 4, HUMAN; HONG KONG; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNX; NF-KAPPA B; PROTEIN STRUCTURE, TERTIARY; REPRESSOR PROTEINS; SEQUENCE DELETION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VIRAL MATRIX PROTEINS;

EID: 3042532226     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207580     Document Type: Article

References (36)

1. Alani RM, Hasskarl J, Grace M, Hernandez MC, Israel MA and Munger K. (1999). Proc. Natl. Acad. Sci. USA, 96, 9637-9641.
2. Beg AA, Ruben SM, Scheinman RI, Haskill S, Rosen CA and Baldwin Jr AS. (1992). Genes Dev., 6, 1899-1913.
3. Blake SM, Eliopoulos AG, Dawson CW and Young LS. (2001). Virology, 282, 278-287.
4. Cahir-Mcfarland ED, Davidson DM, Schauer SL, Duong J and Kieff E. (2000). Proc. Natl. Acad. Sci. USA, 97, 6055-6060.
5. Cheung ST, Leung SF, Lo KW, Chiu KW, Tam JS, Fok TF, Johnson PJ, Lee JC and Huang DP. (1998). Int. J. Cancer, 76, 399-406.
6. Cowley S, Paterson H, Kemp P and Marshall CJ. (1994). Cell, 77, 841-852.
7. Dawson CW, Rickinson AB and Young LS. (1990). Nature, 344, 777-780.
8. Dawson CW, Tramountanis G, Eliopoulos AG and Young LS. (2003). J. Biol. Chem., 278, 3694-3704.
9. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E and Karin M. (1997). Nature, 388, 548-554.
10. Eliopoulos AG and Young LS. (2001). Semin. Cancer Biol., 11, 435-444.
11. Eliopoulos AG, Blake SM, Floettmann JE, Rowe M and Young LS. (1999). J. Virol., 73, 1023-1035.
12. Fahraeus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadav M and Busson P. (1988). Int. J. Cancer, 42, 329-338.
13. Fielding CA, Sandvej K, Mehl A, Brennan P, Jones M and Rowe M. (2001). J. Virol., 75, 9129-9141.
14. Hammerschmidt W, Sugden B and Baichwal VR. (1989). J. Virol., 63, 2469-2475.
15. Hatzivassiliou E and Mosialos G. (2002). Front. Biosci., 7, D319-D329.
16. Jeannel D, Bouvier G and Huber A. (1999). Cancer Surv., 33, 125-155.
17. Kaye KM, Izumi KM and Kieff E. (1993). Proc. Natl. Acad. Sci. USA, 90, 9150-9154.
18. Ling MT, Wang X, Ouyang XS, Lee TK, Fan TY, Xu K, Tsao SW and Wong YC. (2002). Oncogene, 21, 8498-8505.
19. Lo AK, Liu Y, Wang X, Huang DP, Yuen PW, Wong YC and Tsao SW. (2003). Lab. Invest., 83, 1-13.
20. Nehlin JO, Hara E, Kuo WL, Collins C and Campisi J. (1997). Biochem. Biophys. Res. Commun., 231, 628-634.
21. Ohtani N, Brennan P, Gaubatz S, Sanij E, Hertzog P, Wolvetang E, Ghysdael J, Rowe M and Hara E. (2003). J. Cell Biol., 162, 173-183.
22. Ohtani N, Zebedee Z, Huot TJ, Stinson JA, Sugimoto M, Ohashi Y, Sharrocks AD, Peters G and Hara E. (2001). Nature, 409, 1067-1070.
23. Pathmanathan R, Prasad U, Sadler R, Flynn K and Raab-Traub N. (1995). N. Engl. J. Med., 333, 693-698.
24. Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T and Gerritsen ME. (1997). J. Biol. Chem., 272, 21096-21103.
25. Quandt K, Frech K, Karas H, Wingender E and Werner T. (1995). Nucleic Acids Res., 23, 4878-4884.
26. Raab-Traub N. (2002). Semin. Cancer Biol., 12, 431-441.
27. Sanchez I, Hughes RT, Mayer BJ, Yee K, Woodgett JR, Avruch J, Kyriakis JM and Zon LI. (1994). Nature, 372, 794-798.
28. Sham JS, Choy D and Wei WI. (1990). Int. J. Radiat. Oncol. Biol. Phys., 19, 929-933.
29. Sikder HA, Devlin MK, Dunlap S, Ryu B and Alani RM. (2003). Cancer Cell, 3, 525-530.
30. Tsao SW, Tramoutanis G, Dawson CW, Lo AK and Huang DP. (2002a). Semin. Cancer Biol., 12, 473-487.
31. Tsao SW, Wang X, Liu Y, Cheung YC, Feng H, Zheng Z, Wong N, Yuen PW, Lo AK, Wong YC and Huang DP. (2002b). Biochim. Biophys. Acta, 1590, 150-158.
32. Wang D, Liebowitz D and Kieff E. (1985). Cell, 43, 831-840.
33. Wang X, Jin DY, Wong HL, Feng H, Wong YC and Tsao SW. (2003). Oncogene, 22, 109-116.
34. Wang X, Xu K, Ling MT, Wong YC, Feng HC, Nicholls J and Tsao SW. (2002). Mol. Carcinogen., 35, 42-49.
35. Yang XH, Sham JST, Ng MH, Tsao SW, Zhang DK, Lowe SC and Cao L. (2000). J. Virol., 74, 883-891.
36. Zabel U, Schreck R and Baeuerle PA. (1991). J. Biol. Chem., 266, 252-260.